Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Acadia Healthcare Company, Inc.ACHC · Entity 4312 | Director | May 06, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Acadia Healthcare Company, Inc.
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 75,859 |
Ending reported balance
After 2026-05-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-06 · Grant · Acquired 6,331 · Balance 66,283 F1: Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027. Row 2 · 2026-05-06 · Grant · Acquired 9,576 · Balance 75,859 F2: Reflects Mr. Waud's election to receive his annual cash retainer as a director for 2026 in shares of common stock. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 653,015 |
Reported balance
Holding disclosure · report date 2026-05-06 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 653,015 F3: The shares are owned of record as follows: (i) 225,519 shares by the Halcyon Trust, (ii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iii) 155,930 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust"), (v) 43,643 shares by the Cornelius Byron Waud 2002 Trust (the "2002 CBW Family Trust"), and (vi) 34,500 shares by the Corinna Reeve Waud 2002 Trust ("2002 CRW Family Trust"). F4: Mr. Waud may be deemed to beneficially own the shares of common stock described above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries, and (D) his being appointed, in June 2023, as the co-trustee of the 2002 CBW Family Trust and the 2002 CRW Family Trust of which Mr. Waud's parents are beneficiaries. F5: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
F2: Reflects Mr. Waud's election to receive his annual cash retainer as a director for 2026 in shares of common stock.
F3: The shares are owned of record as follows: (i) 225,519 shares by the Halcyon Trust, (ii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iii) 155,930 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust"), (v) 43,643 shares by the Cornelius Byron Waud 2002 Trust (the "2002 CBW Family Trust"), and (vi) 34,500 shares by the Corinna Reeve Waud 2002 Trust ("2002 CRW Family Trust").
F4: Mr. Waud may be deemed to beneficially own the shares of common stock described above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries, and (D) his being appointed, in June 2023, as the co-trustee of the 2002 CBW Family Trust and the 2002 CRW Family Trust of which Mr. Waud's parents are beneficiaries.
F5: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2016 Filed Sep 16, 2016 23:25 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon stock, par value $0.01 per share | 75,000 | $50.76 | $3,807,000.00 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 7 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,337,951 F9 · shares: Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the "Halcyon Trust"). F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.70 to $51.12, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (9) to this Form 4. F14 · balance_after: The shares are owned of record as follows: (i) 1,141,420 shares by WCP II, (ii) 2,086,697 shares by WCP QP II, (iii) 676,113 shares by the Halcyon Trust, (iv) 83,530 shares by Waud Family Partners, L.P. ("WFP LP"), (v) 318,466 shares by WCP FIF II, (vi) 326,164 shares by Waud Affiliates II, (vii) 167,388 shares by Waud Affiliates III, (viii) 454,671 shares by WCP FIF III, (ix) 1,036,001 shares by WCP QP III, (x) 183,205 shares by WCP III, (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 35,296 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), and (xii) 795,667 shares by Crystal Cove LP. F13 · ownership.nature: Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 16, 2016 Filed Sep 16, 2016 23:25 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon stock, par value $0.01 per share | 287,668 | $47.74 | $13,733,270.32 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 6 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,412,951 F8 · shares: Represents shares sold as follows: (i) 7,170 shares by WCP III, (ii) 158,116 shares by Waud QP III, (iii) 89,451 shares by WCP FIF III and (iv) 32,931 shares by Waud Affiliates III. F12 · ownership.nature: Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 16, 2016 Filed Sep 16, 2016 23:25 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon stock, par value $0.01 per share | 521,033 | $47.74 | $24,874,115.42 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 5 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,700,619 F7 · shares: Represents shares sold as follows: (i) 98,073 shares by WCP II, (ii) 296,136 shares by Waud QP II, (iii) 62,655 shares by WCP FIF II and (iv) 64,169 shares by Waud Affiliates II. F11 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 23:25 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon stock, par value $0.01 per share | 123,473 | $49.24 | $6,079,810.52 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 4 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,221,652 F6 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 3,077 shares by WCP III, (ii) 67,867 shares by Waud QP III, (iii) 38,394 shares by WCP FIF III and (iv) 14,135 shares by Waud Affiliates III. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (6) to this Form 4. F12 · ownership.nature: Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 23:25 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon stock, par value $0.01 per share | 223,640 | $49.24 | $11,012,033.60 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 3 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,345,125 F4 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 42,095 shares by WCP II, (ii) 127,109 shares by Waud QP II, (iii) 26,893 shares by WCP FIF II and (iv) 27,543 shares by Waud Affiliates II. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (6) to this Form 4. F11 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 23:25 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon stock, par value $0.01 per share | 46,302 | $50.19 | $2,323,897.38 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 2 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,568,765 F3 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 1,154 shares by Waud Capital Partners III, L.P. ("WCP III"), (ii) 25,449 shares by Waud Capital Partners QP III, L.P. ("Waud QP III"), (iii) 14,397 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") and (iv) 5,302 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (1) and (3) to this Form 4. F12 · ownership.nature: Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 23:25 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon stock, par value $0.01 per share | 83,861 | $50.19 | $4,208,983.59 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,615,067 F1 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 15,785 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 47,664 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"), (iii) 10,084 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") and (iv) 10,328 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (1) and (3) to this Form 4. F11 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 13, 2016 Filed Sep 15, 2016 01:03 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon stock, par value $0.01 per share | 3,275 | $51.23 | $167,778.25 |
DisclosureSEC source: 0000899243-16-029006 · doc4.xml · nonDerivative · entry 4 WAUD REEVE B · CIK 0001421620 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,698,928 F6 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 82 shares by WCP III, (ii) 1,800 shares by Waud QP III, (iii) 1,019 shares by WCP FIF III and (iv) 374 shares by Waud Affiliates III. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.15 to $51.85, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (6) to this Form 4. F9 · balance_after: The shares are owned of record as follows: (i) 1,297,373 shares by WCP II, (ii) 2,557,606 shares by WCP QP II, (iii) 751,113 shares by the Halcyon Exempt Family Trust (the "Halcyon Trust"), (iv) 83,530 shares by Waud Family Partners, L.P. ("WFP LP"), (v) 418,098 shares by WCP FIF II, (vi) 428,204 shares by Waud Affiliates II, (vii) 219,756 shares by Waud Affiliates III, (viii) 596,913 shares by WCP FIF III, (ix) 1,287,433 shares by WCP QP III, (x) 194,606 shares by WCP III, (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 35,296 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), and (xii) 795,667 shares by Crystal Cove LP. F8 · ownership.nature: Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F10 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (9) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F11 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 13, 2016 Filed Sep 15, 2016 01:03 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon stock, par value $0.01 per share | 5,933 | $51.23 | $303,947.59 |
DisclosureSEC source: 0000899243-16-029006 · doc4.xml · nonDerivative · entry 3 WAUD REEVE B · CIK 0001421620 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,702,203 F4 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 1,117 shares by WCP II, (ii) 3,372 shares by Waud QP II, (iii) 713 shares by WCP FIF II and (iv) 731 shares by Waud Affiliates II. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.15 to $51.85, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (6) to this Form 4. F7 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. F10 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (9) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F11 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 12, 2016 Filed Sep 15, 2016 01:03 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon stock, par value $0.01 per share | 26,679 | $51.77 | $1,381,171.83 |
DisclosureSEC source: 0000899243-16-029006 · doc4.xml · nonDerivative · entry 2 WAUD REEVE B · CIK 0001421620 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,708,136 F3 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 665 shares by Waud Capital Partners III, L.P. ("WCP III"), (ii) 14,664 shares by Waud Capital Partners QP III, L.P. ("Waud QP III"), (iii) 8,296 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") and (iv) 3,054 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.58 to $52.01, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (1) and (3) to this Form 4. F8 · ownership.nature: Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F10 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (9) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F11 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 12, 2016 Filed Sep 15, 2016 01:03 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon stock, par value $0.01 per share | 48,321 | $51.77 | $2,501,578.17 |
DisclosureSEC source: 0000899243-16-029006 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,734,815 F1 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 9,095 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 27,464 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"), (iii) 5,811 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") and (iv) 5,951 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.58 to $52.01, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (1) and (3) to this Form 4. F7 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. F10 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (9) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F11 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 22:57 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | OtherCommon stock, par value $0.01 per share | 534,488 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-16-028908 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,783,136 F1 · kind: Represents pro rata in-kind distributions for no consideration to certain of the limited partners of the following Reporting Persons: (i) 214,308 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 193,821 shares by Waud Capital Partners QP II, L.P. ("WCP QP II"), (iii) 48,921 shares by Waud Capital Partners III, L.P. ("WCP III") and (iv) 77,438 shares by Waud Capital Partners QP III, L.P. ("WCP QP III"). F1 · shares: Represents pro rata in-kind distributions for no consideration to certain of the limited partners of the following Reporting Persons: (i) 214,308 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 193,821 shares by Waud Capital Partners QP II, L.P. ("WCP QP II"), (iii) 48,921 shares by Waud Capital Partners III, L.P. ("WCP III") and (iv) 77,438 shares by Waud Capital Partners QP III, L.P. ("WCP QP III"). F2 · balance_after: The shares are owned of record as follows: (i) 1,307,585 shares by WCP II, (ii) 2,588,442 shares by WCP QP II, (iii) 751,113 shares by the Halcyon Exempt Family Trust (the "Halcyon Trust"), (iv) 83,530 shares by Waud Family Partners, L.P. ("WFP LP"), (v) 424,622 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II"), (vi) 434,886 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"), (vii) 223,184 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"), (viii) 606,228 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III"), (ix) 1,303,897 shares by WCP QP III, (x) 195,353 shares by Waud Capital Partners III, L.P. ("WCP III"), (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 35,296 shares by WCP LLC, and (xii) 795,667 shares by Crystal Cove LP. F3 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F4 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (2) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F5 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.